LegalView Announces Reglan Information Portal Launch
LegalView.info, the definitive authority concerning personal injury legal access online, announced this week the launch of a new information portal, this one regarding the drug Reglan.
Denver, CO, August 07, 2009 --(PR.com)-- The newest addition to the LegalView family is a Reglan information portal, providing information concerning potential Reglan side effects which could present in the form of a serious movement disorder. With the launch of the new Reglan site, LegalView now provides a comprehensive landing point for individuals seeking resources regarding Reglan, metoclopramide, or tardive dyskinesia.
Recent reports have provided information on the potentially serious nature of side effects of reglan. These reports show a statistically significant percentage of patients taking medications containing metoclopramide including Reglan Tablets, Reglan Oral Disintegrating Tablets, Metoclopramide Oral Solution, and Reglan Injection are at risk of developing a serious movement disorder known as tardive dyskinesia. Chances of developing this debilitating and oftentimes irreversible condition show a marked increase in patients taking medications containing metoclopramide for longer than 12 weeks; an almost 20 percent increase of development of tardive dyskinesia in patients on an extended regimen of drugs containing metoclopramide.
Tardive dyskinesia is a chronic and almost always irreversible movement disorder characterized by involuntary, repetitive movements of the extremities. These symptomatic movements appear as facial tics like grimacing, lip smacking and tongue protrusion, pursing of the lips, or impaired movement of the fingers. Some patients also experience rapid eye movements or blinking in addition to the other tics. These symptoms are rarely reversible; there is currently no known treatment, though some patients show diminished or disappearing symptoms after metoclopramide treatment is stopped. Many patients can seek legal recourse by contacting a Reglan attorney.
As this information became available to the public and government officials, the Food and Drug Administration (FDA) instituted several requirements for labeling drugs containing metoclopramide. In February 2009, the FDA warned against use of medication that containing metoclopramide for longer than 12 weeks. In March of 2009, the FDA published a section on Reglan in their monthly MedWatch Safety Alert newsletter, reporting that long-term use of drugs containing metoclopramide could result in a tardive dyskinesia. Again in June 2009, the FDA published an announcement requiring all medications containing metoclopramide, including Reglan and all of its incarnations, to carry a strong warning advising that the potential to develop serious side effects after extended use.
Since such serious side effects exist for medication commonly prescribed, many patients adversely affected have expressed interest in contacting a Reglan Lawyer to pursue legal action. As LegalView remains committed to assisting all individuals who may have been injured due to serious drug side effects, the launch of their Reglan information portal marks yet another step toward increasing consumer safety and drug company accountability. Since the effects of tardive dyskinesia could potentially be debilitating or incapacitating, it may leave those suffering from this condition unable to work or support their families. Additionally, treatments could be costly far beyond a typical individuals insurance coverage. To this end, it is important for an individual to pursue the development of a possible Reglan Lawsuit in order to potentially provide monetary compensation and subsequently cover these unforseeable expenses.
About LegalView:
Legalview.info is a public service brought to yo by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of Legalview.info's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.Legalview.info.
###
Recent reports have provided information on the potentially serious nature of side effects of reglan. These reports show a statistically significant percentage of patients taking medications containing metoclopramide including Reglan Tablets, Reglan Oral Disintegrating Tablets, Metoclopramide Oral Solution, and Reglan Injection are at risk of developing a serious movement disorder known as tardive dyskinesia. Chances of developing this debilitating and oftentimes irreversible condition show a marked increase in patients taking medications containing metoclopramide for longer than 12 weeks; an almost 20 percent increase of development of tardive dyskinesia in patients on an extended regimen of drugs containing metoclopramide.
Tardive dyskinesia is a chronic and almost always irreversible movement disorder characterized by involuntary, repetitive movements of the extremities. These symptomatic movements appear as facial tics like grimacing, lip smacking and tongue protrusion, pursing of the lips, or impaired movement of the fingers. Some patients also experience rapid eye movements or blinking in addition to the other tics. These symptoms are rarely reversible; there is currently no known treatment, though some patients show diminished or disappearing symptoms after metoclopramide treatment is stopped. Many patients can seek legal recourse by contacting a Reglan attorney.
As this information became available to the public and government officials, the Food and Drug Administration (FDA) instituted several requirements for labeling drugs containing metoclopramide. In February 2009, the FDA warned against use of medication that containing metoclopramide for longer than 12 weeks. In March of 2009, the FDA published a section on Reglan in their monthly MedWatch Safety Alert newsletter, reporting that long-term use of drugs containing metoclopramide could result in a tardive dyskinesia. Again in June 2009, the FDA published an announcement requiring all medications containing metoclopramide, including Reglan and all of its incarnations, to carry a strong warning advising that the potential to develop serious side effects after extended use.
Since such serious side effects exist for medication commonly prescribed, many patients adversely affected have expressed interest in contacting a Reglan Lawyer to pursue legal action. As LegalView remains committed to assisting all individuals who may have been injured due to serious drug side effects, the launch of their Reglan information portal marks yet another step toward increasing consumer safety and drug company accountability. Since the effects of tardive dyskinesia could potentially be debilitating or incapacitating, it may leave those suffering from this condition unable to work or support their families. Additionally, treatments could be costly far beyond a typical individuals insurance coverage. To this end, it is important for an individual to pursue the development of a possible Reglan Lawsuit in order to potentially provide monetary compensation and subsequently cover these unforseeable expenses.
About LegalView:
Legalview.info is a public service brought to yo by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of Legalview.info's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.Legalview.info.
###
Contact
LegalView
Ryan Smith
720-226-6613
http://reglan.legalview.info
Ryan Smith
720-226-6613
http://reglan.legalview.info
Contact
Categories